News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
MIG Capital and CoreMedic announce fresh funding in Series B Extension
MIG Capital and CoreMedic secure fresh funding in Series B Extension for innovative transcatheter mitral valve repair device, ChordArt, to address unmet medical need of mitral valve regurgitation. Funding fuels First-in-human study -
-
-